About Us

Our Mission

Our mission focuses on both medical treatment and scientific research. Harnessing the unique qualities of human non-embryonic umbilical cord serum (Wharton’s Jelly). We pursue the following goals:

  • Provide and use our products for safe, innovative tissue repair and regenerative therapy.
  • Enhance and expand our treatments and products by applying findings from the ever-evolving and innovative field of regenerative medical research.
  • Partner with other research groups in clinical and laboratory studies that are focused on broadening the scope and improving the effectiveness of regenerative medicine.
Migraine

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Shoulder

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Elbow

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Arthritis

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Joint Pain & Meniscus Tears

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Drop Foot

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Cervical Treatment

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Rotator Cuff Tears

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Degenerative Disc Disease
Sciatica

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Hip Pain
Tenditis of the thigh

Lorem ipsum dolor sit sodales, augue velit cursus nunc.

Peripheral Neuropathy

Learn how regenerative medicine can help you.

These are just a few of the many issues that our innovative tissue repair and regenerative therapy can heal.

DISCLAIMER

*** SCROLL TO BOTTOM ***

CLICK ON "I Have Read & Understand The Disclaimer"

One Umbilical Cord Lab (OUCL) is intended as a medical site and offers training, services, and products for the general public and the medical community.
The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing alternative bio-ethical therapies seeking to establish efficacy, these are not at the point where they would meet the scientific standard.
The FDA has stated: Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.
If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.
“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.
If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products. 
Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage. Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.
One Umbilical Cord Lab (OUCL) does not sell or manufacture stem cell products as defined by the FDA.  OUCL only manufactures a proprietary blend of Proteins, Peptides, and Growth Factors scientifically derived from Wharton’s jelly.  None of our products contain red or white blood cells.